Department of Clinical Research Design and Evaluation, SAIHST, Sungkyunkwan University, Seoul, Korea.
Center for Clinical Epidemiology, Samsung Medical Center, Sungkyunkwan University, Seoul, Korea.
Cancer Res Treat. 2023 Jan;55(1):61-72. doi: 10.4143/crt.2021.1583. Epub 2022 Feb 23.
The purpose of the study was to validate the Korean version of Cancer Survivors' Unmet Needs (CaSUN) scale among non-small cell lung cancer survivors.
Participants were recruited from outpatient clinics at the Samsung Medical Center in Seoul, South Korea, from January to October 2020. Participants completed a survey questionnaire that included the CaSUN. Exploratory and confirmatory factor analysis and Pearson's correlations were used to evaluate the reliability and validity of the Korean version of the CaSUN (CaSUN-K). We also tested known-group validity using an independent t test or ANOVA.
In total, 949 provided informed consent and all of which completed the questionnaire. Among the 949 patients, 529 (55.7%) were male; the mean age and median time since the end of active treatment (standard deviation) was 63.4±8.8 years and the median was 18 months. Although the factor loadings were different from those for the original scale, the Cronbach's alpha coefficients of the six domains in the CaSUN-K ranged from 0.68 to 0.95, indicating satisfactory internal consistency. In the CFA, the goodness-of-fit indices for the CaSUN-K were high. Moderate correlations demonstrated the convergent validity of CaSUN-K with the relevant questionnaire. More than 60% of the participants reported information-related unmet needs, and the CaSUN-K discriminated between the needs reported by the different subgroups that we analyzed.
The CaSUN-K is a reliable and valid measure for assessing the unmet needs in a cancer population, thus this tool help population to receive timely, targeted, and relevant care.
本研究旨在验证非小细胞肺癌幸存者的韩国版癌症幸存者未满足需求(CaSUN)量表。
参与者于 2020 年 1 月至 10 月期间在首尔三星医疗中心的门诊招募。参与者完成了一份包括 CaSUN 的调查问卷。采用探索性和验证性因子分析和 Pearson 相关系数评估 CaSUN-K 的可靠性和有效性。我们还使用独立 t 检验或 ANOVA 测试了已知组的有效性。
共有 949 人同意提供知情同意并完成了问卷。在这 949 名患者中,529 名(55.7%)为男性;平均年龄和自主动治疗结束后的中位数(标准差)为 63.4±8.8 岁,中位数为 18 个月。尽管因子负荷与原始量表不同,但 CaSUN-K 的六个领域的 Cronbach's alpha 系数范围为 0.68 至 0.95,表明具有令人满意的内部一致性。在 CFA 中,CaSUN-K 的拟合优度指数较高。CaSUN-K 与相关问卷的中等相关性表明了其收敛有效性。超过 60%的参与者报告了与信息相关的未满足需求,并且 CaSUN-K 可以区分我们分析的不同亚组报告的需求。
CaSUN-K 是评估癌症人群未满足需求的可靠有效工具,因此该工具有助于及时为患者提供有针对性和相关的护理。